Announced Tue, 26 May · 20:50 IST

Reappointment of Internal Auditor of the Company

Management Changes View source PDF

LOTUSEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.7%1-day move
₹110.85
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.7-2.6-1.2+1.0-0.8+5.6+20.2+9.6+7.2
Up moveDown movePending
AI summary

Lotus Eye Hospital and Institute Limited held a Board meeting on May 26, 2026, approving two items: (1) Standalone Audited Financial Results for Q4 and year ended March 31, 2026, and (2) Reappointment of Mr. P Vishnu Adithan, Chartered Accountant, as Internal Auditor for FY 2026-27. For the full year, total income increased to Rs. 5,489.03 lakhs from Rs. 5,086.38 lakhs in the previous year, representing 8% growth. However, the company reported a net loss of Rs. 26.07 lakhs compared to net profit of Rs. 58.97 lakhs in FY 2025. The statutory auditors M/s. Anbarasu & Jalapathi issued an unmodified (clean) opinion on the financial results. The company operates in a single segment of eye care services and has no subsidiaries.

Likely market impact

The reappointment of the internal auditor is a routine matter indicating continuity in internal controls. However, the significant decline in profitability (from profit to loss) may be a concern for investors, though the auditors have given a clean bill of health on the financial statements.